Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1

Abstract

TBK1 is essential for interferon-β (IFN-β) production and innate antiviral immunity. Here we identified the T cell anergy–related E3 ubiquitin ligase RNF128 as a positive regulator of TBK1 activation. RNF128 directly interacted with TBK1 through its protease-associated (PA) domain and catalyzed the K63-linked polyubiquitination of TBK1, which led to TBK1 activation, IRF3 activation and IFN-β production. Deficiency of RNF128 expression attenuated IRF3 activation, IFN-β production and innate antiviral immune responses to RNA and DNA viruses, in vitro and in vivo. Our study identified RNF128 as an E3 ligase for K63-linked ubiquitination and activation of TBK1 and delineated a previously unrecognized function for RNF128.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Viral infection induces RNF128 expression.
Figure 2: RNF128 positively regulates IFN-β signaling.
Figure 3: RNF128 targets TBK1.
Figure 4: RNF128 promotes K63-linked ubiquitination of TBK1.
Figure 5: RNF128 promotes TBK1 activation.
Figure 6: RNF128 is a general regulator of TBK1 activation.
Figure 7: RNF128 positively regulates antiviral response.

Similar content being viewed by others

References

  1. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820 (2010).

    Article  CAS  Google Scholar 

  2. Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738 (2001).

    Article  CAS  Google Scholar 

  3. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730–737 (2004).

    Article  CAS  Google Scholar 

  4. Hornung, V. et al. 5′-triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006).

    Article  Google Scholar 

  5. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001 (2006).

    Article  CAS  Google Scholar 

  6. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006).

    Article  CAS  Google Scholar 

  7. Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).

    Article  CAS  Google Scholar 

  8. Wu, J. & Chen, Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32, 461–488 (2014).

    Article  CAS  Google Scholar 

  9. Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75–86 (2009).

    Article  CAS  Google Scholar 

  10. Li, S., Wang, L., Berman, M., Kong, Y.Y. & Dorf, M.E. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35, 426–440 (2011).

    Article  CAS  Google Scholar 

  11. Wang, C. et al. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat. Immunol. 10, 744–752 (2009).

    Article  CAS  Google Scholar 

  12. Cui, J. et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat. Immunol. 13, 387–395 (2012).

    Article  CAS  Google Scholar 

  13. Zhang, M. et al. TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J. Exp. Med. 209, 1703–1711 (2012).

    Article  CAS  Google Scholar 

  14. Friedman, C.S. et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9, 930–936 (2008).

    Article  CAS  Google Scholar 

  15. Zhang, L., Zhao, X., Zhang, M., Zhao, W. & Gao, C. Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANK-binding kinase 1. J. Immunol. 193, 2230–2237 (2014).

    Article  CAS  Google Scholar 

  16. Anandasabapathy, N. et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18, 535–547 (2003).

    Article  CAS  Google Scholar 

  17. Kriegel, M.A., Rathinam, C. & Flavell, R.A. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance. Proc. Natl. Acad. Sci. USA 106, 16770–16775 (2009).

    Article  CAS  Google Scholar 

  18. Nurieva, R.I. et al. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32, 670–680 (2010).

    Article  CAS  Google Scholar 

  19. Bachmaier, K. et al. E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury. Nat. Med. 13, 920–926 (2007).

    Article  CAS  Google Scholar 

  20. Fang, D. & Liu, Y.C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2, 870–875 (2001).

    Article  CAS  Google Scholar 

  21. Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5, 255–265 (2004).

    Article  CAS  Google Scholar 

  22. Stetson, D.B. & Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93–103 (2006).

    Article  CAS  Google Scholar 

  23. Darnell, J.E. Jr., Kerr, I.M. & Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421 (1994).

    Article  CAS  Google Scholar 

  24. Panne, D., Maniatis, T. & Harrison, S.C. An atomic model of the interferon-β enhanceosome. Cell 129, 1111–1123 (2007).

    Article  CAS  Google Scholar 

  25. Lin, R., Heylbroeck, C., Pitha, P.M. & Hiscott, J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986–2996 (1998).

    Article  CAS  Google Scholar 

  26. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087–1095 (1998).

    Article  CAS  Google Scholar 

  27. Lineberry, N., Su, L., Soares, L. & Fathman, C.G. The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane. J. Biol. Chem. 283, 28497–28505 (2008).

    Article  CAS  Google Scholar 

  28. Lineberry, N.B. et al. Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J. Immunol. 181, 1622–1626 (2008).

    Article  CAS  Google Scholar 

  29. Su, L.L., Iwai, H., Lin, J.T. & Fathman, C.G. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. J. Immunol. 183, 438–444 (2009).

    Article  CAS  Google Scholar 

  30. Tu, D. et al. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 3, 747–758 (2013).

    Article  CAS  Google Scholar 

  31. Larabi, A. et al. Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep. 3, 734–746 (2013).

    Article  CAS  Google Scholar 

  32. Kishore, N. et al. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J. Biol. Chem. 277, 13840–13847 (2002).

    Article  CAS  Google Scholar 

  33. van Boxel-Dezaire, A.H., Rani, M.R. & Stark, G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361–372 (2006).

    Article  CAS  Google Scholar 

  34. Sahoo, A., Alekseev, A., Obertas, L. & Nurieva, R. Grail controls Th2 cell development by targeting STAT6 for degradation. Nat. Commun. 5, 4732 (2014).

    Article  CAS  Google Scholar 

  35. Wang, P., Zhao, W., Zhao, K., Zhang, L. & Gao, C. TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3. PLoS Pathog. 11, e1004726 (2015).

    Article  Google Scholar 

  36. Mori, M. et al. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279, 9698–9702 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank G.C. Fathman (Stanford University School of Medicine), K.A. Fitzgerald (University of Massachusetts Medical School) and H.-b. Shu (Wuhan University) for providing RNF128 expression plasmids, IFN-β reporter and TBK1 mutant plasmid S172A, respectively. We thank B. Sun (Institut Pasteur of Shanghai, Chinese Academy of Sciences) for providing TBK1-deficient MEFs, and H. Meng (Institute of Basic Medicine, Shandong Academy of Medical Sciences) for VSV and HSV-1. This work was supported in part by grants from the Natural Science Foundation of China (81525012, 81471538, 81273219) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20130131130010) to C.G. G.J. is a Taishan Scholar of Shandong, China.

Author information

Authors and Affiliations

Authors

Contributions

C.G. conceived and supervised the study. G.S. performed most of the experiments and prepared the figures. B.L. performed part of the ubiquitination experiments. H.W., P.W., K.Z. and L.Z. provided reagents and contributed to discussions. Z.L. and G.J. provided facility for virus study. G.S. and C.G. analyzed the data and wrote the paper.

Corresponding author

Correspondence to Chengjiang Gao.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Virus infection induces RNF128 expression.

(a,b) RT-PCR analysis of R nf128 (RNF128) mRNA expression in mouse peritoneal macrophages (a) and THP-1 cells (b) upon stimulation with poly(I:C) and ISD or infection with SeV and HSV-1 for indicated times. Data are representative of three independent experiments with similar results.

Supplementary Figure 2 RNF128 positively regulates IFN-β signaling.

(a) Quantitative RT-PCR analysis of Rnf128 mRNA expression (upper) and western blot analysis of RNF128 protein expression (lower) in mouse peritoneal macrophages transfected with control siRNA or mice RNF128 siRNA 1, 2 or 3 for 48 h. (b) mRNA expression of Ifnb1, Cxcl10, Mx1, Ccl5, Il6 and Tnfa in mouse peritoneal macrophages transfected with control siRNA or mice RNF128 siRNA 1, 2 or 3 and then stimulated with poly(I:C) and ISD or infected with SeV and HSV-1. (c) Quantitative RT-PCR analysis of RNF128 mRNA expression (upper) and western blot analysis of RNF128 protein expression (lower) in THP-1 cells transfected with control siRNA or human RNF128 siRNA 1, 2 or 3 for 48 h. (d) Quantitative RT-PCR analysis of IFNB1, CXCL10, MX1, CCL5, IL6 and TNFA mRNA expression in THP-1 cells transfected with control siRNA or human RNF128 siRNA 1, 2 or 3 for 48 h and then stimulated with poly(I:C) and ISD or infected with SeV and HSV-1. (e) Quantitative RT-PCR analysis of Ifnb1, Cxcl10, Mx1, Ccl5, Il6 and Tnfa mRNA expression in WT or Rnf128−/− mouse peritoneal macrophages stimulated with LPS for the indicated time. (f,g) Luciferase activity of IFN-β promoter reporter and mRNA expression of IFNB1 in HEK293 cells transfected with expression plasmids for TRIF, cGAS+STING and RIG-IN along with V5-RNF128 expression plasmid or control vector for 24 h. *p <0.05,# p <0.01 (two-tail Student's t-test). Data are from three independent experiments (a-f; mean+S.D. of triplicate assays) or are representative of three independent experiments with similar results (a,b).

Supplementary Figure 3 RNF128 promotes IRF3 activation.

(a) Luciferase activity in HEK293 cells transfected with IFN-β, PRDI-III, PRDII, PRDIV luciferase reporter and RNF128 expression plasmid together with expression plasmids for TRIF, MAVS, cGAS+STING or control plasmid. (b) Western blot analysis of phosphorylated-IRF3 in HEK293 cells transfected with RNF128 expression plasmid or control plasmid, along with expression plasmids for TRIF, MAVS, cGAS+STING or control plasmid. (c) Western blot analysis of phosphorylated-IRF3 protein in HEK293 cells transfected with expression plasmids for MAVS and increased amount of V5-RNF128 plasmid. *p <0.05,** p <0.01 (two-tail Student's t-test). Data are from three independent experiments (a; mean±S.D. of triplicate assays) or are representative of three independent experiments with similar results (b,c).

Supplementary Figure 4 RNF128 targets TBK1.

(a) Coimmunoprecipitation analysis of RNF128 interaction with TBK1 in THP-1 cells infected with SeV or HSV-1 for 8 h. (b) ISRE luciferase activity in HEK293 cells transfected with V5-RNF128 expression plasmid or mutant plasmids together with expression plasmids as indicated. (c) Western blot analysis of phosphorylated-IRF3 protein in HEK293 cells transfected with expression plasmids for RNF128 expression plasmid or the mutants and MAVS or cGAS and STING expression plasmids. (d) Coimmunoprecipitation analysis of MAVS ubiquitination in primary macrophages from WT and Rnf128−/− mice were infected with SeV. (e) Coimmunoprecipitation analysis of STING ubiquitination in primary macrophages from WT and Rnf128−/− mice were infected with HSV-1. **p <0.01 (two-tail Student's t-test). Data are representative of three independent experiments with similar results (a,c-e) or are from three independent experiments (b; mean±S.D. of triplicate assays).

Supplementary Figure 5 RNF128 positively regulates TBK1 kinase activity.

(a) TBK1kinase activity assays in HEK293 cells transfected with the RNF128 expression plasmid and then infected with SeV for 6 h. (b) TBK1 kinase activity assays in peritoneal macrophages transfected with mice RNF128 siRNA, then the cells were infected with SeV for 6 h. (c) Quantitative RT-PCR analysis of mRNA expression of Ifnb1 (upper) and western blot analysis of phosphorylated-TBK1 protein (lower) in TBK1 deficient MEFs transfected with expression plasmids for Myc-TBK1-WT or Myc-TBK1-S172A along with V5-RNF128 plasmids. *p <0.05, **p <0.01, ns, not significant (two-tail Student's t-test). Data are from three independent experiments (a,b; mean±S.D. of triplicate assays) or are representative of three independent experiments with similar results (c-h).

Supplementary Figure 6 RNF128 positively regulates antiviral response.

(a) VSV titers and VSV-G protein in HEK293 (2×105) transfected with the V5-RNF128-WT, mutant V5-RNF128-H2N2 and V5-RNF128-PA expression plasmid and then infected with VSV (MOI, 0.1). (b) VSV titers and VSV-G protein in mouse peritoneal macrophages transfected with control siRNA or RNF128 siRNA and then infected with VSV (MOI, 0.1). (c) HSV-1 genomic DNA and titers in mouse primary macrophages transfected with control siRNA or RNF128 siRNA and then infected by HSV-1 (MOI, 10). (d) VSV titers and VSV-G protein in THP-1 cells transfected with control siRNA or RNF128 siRNA and then infected with VSV (MOI, 0.1). (e) HSV-1 titers and genomic DNA in THP-1 cells transfected with control siRNA or RNF128 siRNA and then infected by HSV-1 (MOI, 10). *p <0.05, **p <0.01 (two-tail Student's t-test). Data are from three independent experiments (a-e; mean±S.D. of triplicate assays) or are representative of three independent experiments with similar results (a,b,d).

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–6 and Supplementary Tables 1–3 (PDF 1438 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, G., Liu, B., Li, Z. et al. E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. Nat Immunol 17, 1342–1351 (2016). https://doi.org/10.1038/ni.3588

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.3588

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing